Mesa Laboratories Inc /Co/ (NASDAQ: MLAB)

Mesa Laboratories, Inc. is a global provider of life sciences tools and critical quality control solutions for the pharmaceutical healthcare and medical device industries. The company designs manufactures and sells products that help customers ensure product integrity increase patient and worker safety and improve quality of life worldwide.

Mesa Laboratories, Inc. generates revenue from the sale of products including consumables and hardware and from the provision of services such as maintenance calibration and testing. Its customers span hospitals dental offices pharmaceutical manufacturers medical device companies contract sterilization providers clinical research labs academic institutions and government agencies.

The company operates through the following segments: Sterilization and Disinfection Control Clinical Genomics Biopharmaceutical Development and Calibration Solutions.

• Sterilization and Disinfection Control manufactures and sells biological chemical and cleaning indicators used to assess the effectiveness of sterilization decontamination disinfection and cleaning processes in pharmaceutical medical device and healthcare industries; the division also provides testing and laboratory services mainly to dental and pharmaceutical industries; its product portfolio includes inoculated carriers self contained indicators process challenge devices and growth materials; manufacturing occurs in Bozeman Montana Waldems Germany and Munich Germany; customers include industrial users hospitals dental offices and contract sterilization providers.

• Clinical Genomics develops manufactures and sells highly sensitive low cost high throughput genetic analysis tools and related consumables and services that enable clinical research labs and contract research organizations to perform genomic testing for a broad range of research applications in several therapeutic areas; the MassARRAY system together with proprietary consumables such as chips panels and chemical reagent solutions supports DNA analysis for inherited disease testing pharmacogenetics oncology infectious disease testing doping toxicology and other research uses; about seventy five percent of segment revenue comes from consumables fifteen percent from hardware and the remainder from service and support agreements; customers include clinical research labs contract research organizations large specialty reference pathology labs academic hospital and government facilities with the majority of sales in the United States and China; manufacturing is located in San Diego California.

• Biopharmaceutical Development develops manufactures sells and services automated systems for protein analysis immunoassays and peptide synthesis solutions that accelerate the discovery development and manufacture of biologic therapies; the division offers protein analysis solutions including Gyrolab xPand and Gyrolab xPlore hardware Gyrolab Bioaffy microfluidic disks kits and buffers and peptide synthesis solutions such as PurePep Symphony and Chorus instruments and EasyClean consumables; service agreements support instruments sold by the division; in fiscal year 2025 about thirty five percent of revenue derived from consumables forty percent from hardware and the remainder from service; customers are biopharmaceutical research development and manufacturing teams at biopharma companies and their contract research organization partners as well as academic research and development laboratories; manufacturing sites are in Uppsala Sweden and Tucson Arizona; the segment is more sensitive to foreign currency fluctuations due to costs incurred in Swedish krona while sales are in US dollars or euros.

• Calibration Solutions develops manufactures sells and services quality control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications such as renal care environmental and process monitoring gas flow air quality and torque testing primarily in medical device manufacturing pharmaceutical manufacturing laboratory and hospital environments; product lines include continuous monitoring systems dialysate meters and consumables data loggers gas flow calibration and air sampling equipment and torque testing systems; manufacturing facilities are located in Lakewood Colorado and Hanover Germany; customers comprise dialysis facilities medical device manufacturers biomedical service companies hospitals pharmacies laboratories and other entities requiring regulatory compliance and quality assurance.

Mesa Laboratories, Inc. positions itself as a global leader in life sciences tools and critical quality control solutions competing on the basis of quality flexibility cost effectiveness and suitability for intended use; the company believes it is one of the leading worldwide suppliers of protein analysis and peptide synthesis equipment for biologics discovery and development markets; in the Calibration Solutions segment it maintains a strong competitive position in North America while acknowledging limited presence outside the United States and Canada; overall the firm leverages proprietary technology a diversified product portfolio and a customer focused approach to differentiate itself from rivals.

Mesa Laboratories, Inc. serves a diverse customer base that includes hospitals dental offices pharmaceutical manufacturers medical device companies contract sterilization providers clinical research labs contract research organizations academic institutions government agencies dialysis facilities biomedical service companies and laboratories requiring environmental monitoring and quality control.